Status epilepticus: Behandlung und Typen von Roy Strowd, MD

video locked

Über den Vortrag

Der Vortrag „Status epilepticus: Behandlung und Typen“ von Roy Strowd, MD ist Bestandteil des Kurses „Anfälle und Epilepsie“.


Quiz zum Vortrag

  1. Repeat dosing of abortive antiepileptic medication can be given during stage 2.
  2. ABCs, IV access, and glucose testing occur in stage 2.
  3. Abortive antiepileptic medication is given in stage 1.
  4. Thiamine is recommended for neonates.
  5. Pyridoxine is recommended for adults.
  1. Approximately half of the patients treated for SE will progress to refractory SE.
  2. Definitive medical treatment for SE is successful in the vast majority of cases.
  3. Levetiracetam has a significantly higher efficacy.
  4. Valproate has a significantly higher efficacy.
  5. All three definitive medications have an efficacy rate of approximately 75%.
  1. Neuroimaging may be performed to locate a possible nidus.
  2. Additional medications are avoided during this phase.
  3. A medically induced coma is initiated for 12 hours.
  4. Patients are usually less symptomatic at this stage and can be managed on the hospital floor.
  5. Refractory SE is a relatively safe period with minimal risk of brain damage.
  1. In temporal lobe epilepsy, surgical resection may be more effective than prolonged medical therapy.
  2. Patients must fail 48 hours of burst suppression before they reach this classification.
  3. There is clear evidence of a specific treatment modality offering the highest efficacy.
  4. Increasing dietary carbohydrates may be an effective treatment approach during this stage.
  5. Outcomes of vagus nerve stimulation have been poor, resulting in abandonment of the modality.

Dozent des Vortrages Status epilepticus: Behandlung und Typen

 Roy Strowd, MD

Roy Strowd, MD

Dr. Roy Strowd is the Assistant Dean of Undergraduate Medical Education at the Wake Forest Baptist Medical Center, in North Carolina, USA.
He obtained his MD from Wake Forest School of Medicine in 2009, and his MEd from Johns Hopkins University in 2021. Currently, he co-directs the Neurofibromatosis and Tuberous Sclerosis Clinics at Wake Forest Baptist Medical Center, and is a researcher for the Adult Brain Tumor Consortium (ABTC) and Alliance for Clinical Trials in Neuro-Oncology.
Due to his achievements, he earned the M. Brownell Anderson Award from the Association of American Medical Colleges.
Within Lecturio, Dr. Strowd teaches courses on Clinical Neurology.


Kundenrezensionen

(1)
5,0 von 5 Sternen
5 Sterne
5
4 Sterne
0
3 Sterne
0
2 Sterne
0
1  Stern
0